Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

MRK 51.59 -1.06 (-2.01%)
price chart
Merck Company Foundation Announces HIV Care Collaborative with Atlanta ...
19 /CSRwire/ - The Merck Company Foundation announces the launch of a three-year, $3 million initiative that will support the health departments in Atlanta, Houston and Philadelphia to connect more people living with HIV in these high-burden ...
CEOs Call on Countries to Lift Travel Restrictions for People Living with HIV  UNAIDS (press release)
HIV Travel Restrictions In 46 Countries Opposed By Top CEOs At 2012 ...  International Business Times
Merck Launches Richard T. Clark Fellowship Program with PSI Partnership
“The Richard T. Clark Fellowship program represents the best of what is possible in private-public partnerships for global health.
Merck & Co and Dashtag plans to acquire 21% stake in Fulford (India) through ...
Merck & Co. Inc. and Dashtag, have decided to acquire 21.07 per cent equity stake (8.22 lakh equity shares) of Fulford (India) through voluntary open offer at a price of Rs 830 per share of Rs.10 each aggregating to Rs.68.22 crore.
37 African American Students Awarded Prestigious UNCF/MERCK Science Initiave ...
The Merck Company Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global healthcare leader, the Foundation is funded entirely by the company and is Merck's chief source of funding support to qualified non ...
Weekend fire at Merck facility quickly contained
A Towamencin Volunteer Fire Company engine arrives at Merck & Co. following a report of a fire spreading across a building roof in the company's complex Sunday.
Pre-Market Movers (AIG, DryShips, Merck, Complete Genomics, SAP, Deutsche Bank ...
Merck & Co Inc. (MRK) stock advanced 2.18 percent to $42.11 in pre-market trading. The company plans to close an advanced clinical study of its osteoporosis drug after an interim analysis showed that the trial met its primary efficacy goals, and that ...
Merck tests sleeping pill with fewer side effects
Takeda's Rozerem, approved in the U.S. in 2005, generated just $11.7 million in sales last year for the Osaka, Japan-based drugmaker, while Somaxon Pharmaceuticals Inc.'s Silenor had only $16.2 million in sales last year. The newer therapies failed ...
New Sleeping Pill Thwarts Brain's Up-All-Night Neurons  Bloomberg
How They Won It: Lowenstein Breaks Ground With Schering Win
Law360, New York (July 10, 2012, 5:23 PM ET) -- Attorneys for Lowenstein Sandler PC didn't just preserve a win for Schering-Plough Corp.
Merck, Whole Foods, Google, Wang Lo Kat: Intellectual Property
July 17 (Bloomberg) -- Merck & Co. ... The European Union's antitrust chief said he'd rather settle an antitrust probe over claims Google Inc. discriminates against rivals than pursue an enforcement action against the world's largest Web-search engine.
Merck licenses 2 new compounds against HIV virus
Merck, based in Whitehouse Station, N.J., said Tuesday that it's signed one deal with Chimerix Inc. for a compound called CMX157, a pill in the HIV drug class called nucleoside reverse transcriptase inhibitors that's now in early patient testing.
Merck Steps Further into HIV Space  Genetic Engineering News
Chimerix strikes drug license deal with Merck  Upstart (blog)